Sinovac Biotech Stock (NASDAQ: SVA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / - |
Day Range | - - - |
52 Wk Range | - - - |
Market Cap | $582.088M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | - |
Days to Cover | 999.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sinovac Biotech (NASDAQ: SVA) through any online brokerage.
Other companies in Sinovac Biotech’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Sinovac Biotech (NASDAQ: SVA) was reported by Morgan Stanley on Thursday, March 20, 2014. The analyst firm set a price target for 0.00 expecting SVA to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Sinovac Biotech (NASDAQ: SVA) is $5.85 last updated December 24, 2018 at 9:29 AM EST.
There are no upcoming dividends for Sinovac Biotech.
Sinovac Biotech’s FY earnings are confirmed for Friday, May 3, 2024.
There is no upcoming split for Sinovac Biotech.
Sinovac Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.